Document detail
ID
oai:HAL:hal-03990855v1
Topic
antiviral drug repurposing replica... antiviral drug repurposing replication entry immune modulator [SDV]Life Sciences [q-bio] [CHIM]Chemical SciencesAuthor
Terrier, Olivier Slama-Schwok, AnnyLangue
enEditor
HAL CCSD;Kluwer
Category
Chemical Sciences
Year
2021
listing date
12/15/2023
Keywords
repurposing virus treatment influenza antiviral drugAbstract
International audience; Influenza infections remain a major and recurrent source of public health concern.
Together with vaccines, antiviral drugs play a key role in the prevention and treatment of influenza virus infection and disease.
Today, the number of antiviral molecules approved for the treatment of influenza is relatively limited and their use is threatened by the emergence of viral strains with resistance mutations.
There is therefore a real need to expand the prophylactic and therapeutic arsenal.
This chapter summarizes the state of the art in drug discovery and development for the treatment of influenza virus infections, with a focus on both virus-targeting and host-cell-targeting strategies.
Novel antiviral strategies targeting other viral proteins or targeting the host cell, some of which are based on drug repurposing, may be used in combination to strengthen our therapeutic arsenal against this major pathogen.
Terrier, Olivier,Slama-Schwok, Anny, 2021, Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means, HAL CCSD;Kluwer
